NOF Statement on Access to Osteoporosis Medications Covered Under Medicare Part B During COVID-19 Pandemic »

| Advocacy, NOF in the News, Osteoporosis in the News

Contact: Claire Gill, Interim CEO claire.gill@nof.org The National Osteoporosis Foundation (NOF), the country’s leading health organization representing 10 million Americans who suffer from osteoporosis, a chronic disease that weakens bone and increases a person’s risk for debilitating and deadly fractures, urges Members of Congress to assure that patients who are covered by Medicare Part B… Read more »

Legislation to Assist in Restoring Patient Access to DXA Testing »

| Advocacy

NOF and colleagues in the Fracture Prevention Coalition are supporting legislation – HR 2693 and S283 in Congress. This legislation would help ensure that patients have access to DXA testing by restoring Medicare funding for DXA. We are grateful to the following Members of Congress who have signed on as co-sponsors of this important legislation. Below is a… Read more »

DXA Testing by the Numbers – Updated »

| Advocacy

Osteoporosis is under-diagnosed in the Medicare population and the DXA scans are the gold standard for osteoporosis diagnosis, yet in 2007, CMS began significantly reducing reimbursement for DXA scans. This reduced the number of physicians in private offices offering DXA. As a result, fewer women and men were scanned resulting in a decline in osteoporosis… Read more »

National Bone Health Policy Institute Responds to Proposed Rules »

| Advocacy

NOF on behalf of the NBHPI has submitted comments to CMS and HHS regarding proposed rules that could impact osteoporosis patients access to testing and treatment. Comment letters have been submitted for the following: December 31, 2019 – Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs CMS-5528-ANPRM January 25,… Read more »

NOF Statement on Medicare Part B »

| Advocacy, NOF in the News

Washington, DC (October 25, 2018) – The National Osteoporosis Foundation issued the following statement regarding announced changes the Medicare Part B program: “Medicare Part B is vital to patients living with and managing chronic illnesses, like osteoporosis. Key to treatment under the program is the ability for doctors and patients to tailor care to the… Read more »

DXA Testing by the Numbers »

| Advocacy

Osteoporosis is under-diagnosed in the Medicare population according to a recent CDC NHANES survey. DXA scans are the gold standard for osteoporosis diagnosis, yet in 2007, CMS began significantly reducing reimbursement for DXA scans. This reduced the number of physicians in private offices offering DXA. As a result, fewer women and men were scanned resulting… Read more »

NOF Statement On Medicare Open Enrollment »

| Advocacy, NOF in the News, Press Releases

Patient Group Urges Fix To DXA Screening Reimbursement Rates To Encourage More Osteoporosis Screenings Today, as Medicare Open Enrollment starts, the National Osteoporosis Foundation (NOF) urged policymakers to raise the reimbursement rates for x-ray absorptiometry (DXA) screenings, which are the gold standard for osteoporosis screenings. Currently, bipartisan bills are sitting in both Chambers that would… Read more »

NOF Statement on Medicare Part D Cliff »

| Advocacy

Washington, DC  – The National Osteoporosis Foundation issued the following statement regarding the impending out-of-pocket cliff threatening the Medicare Part D program: “A looming threat to the Medicare Part D program is set to take effect in 2020 unless Congress takes action. The Part D cliff will significantly increase the catastrophic threshold – the amount… Read more »

NOF is Advocating for Increased Medicare Reimbursement for DXA Scans »

| Advocacy

Fractures related to osteoporosis threaten the health and independence of older Americans.  And fractures are common:  more than 2 million fractures happen each year due to osteoporosis.  The statistics are staggering and unnecessary. A DXA (Dual-energy X-ray absorptiometry) bone density test is a non-invasive, simple, yet top quality test for screening and diagnosing patients that… Read more »